Shoulder Innovations

Shoulder Innovations Debt / Assets

The Debt-to-Assets Ratio of Shoulder Innovations (SI) as of Oct 15, 2026 is 0.09. In the previous year, Debt-to-Assets Ratio was 0.34 — a change of -74.14% (lower).

Debt / Assets

0.09

YoY

-74.14%

Last updated:

Debt-to-Assets Ratio of Shoulder Innovations is 2025 0.09 . Debt-to-Assets Ratio of Shoulder Innovations was 2024 0.34 . It decreases by -74.14% lower compared to the previous year.

The Shoulder Innovations Debt / Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt / Assets
Date
Debt / Assets
Jan 1, 2018
0.01 USD
Jan 1, 2019
0.01 USD
Jan 1, 2020
0.00 USD
Jan 1, 2021
0.00 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.27 USD
Jan 1, 2024
0.34 USD
Jan 1, 2025
0.09 USD
The Shoulder Innovations Debt / Assets history
YEARDebt / AssetsYoY
0.09-74.14%
0.34+28.34%
0.27+232,829.73%
0.00-88.56%
0.00-65.10%
0.00-69.52%
0.01-10.31%
0.01-9.88%
0.01-50.40%
0.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Shoulder Innovations Stock analysis

What does Shoulder Innovations do? Shoulder Innovations Inc, with ticker SI and ISIN US82537J1088, is a US-based health care company headquartered in Grand Rapids. The company operates in the Health Care sector, specifically within the Health Care Equipment & Supplies industry. Shoulder Innovations Inc has 72 employees and is scheduled to go public on July 31, 2025. The company focuses on developing advanced implant systems for shoulder arthroplasty, aiming to transform the shoulder surgical care market. Its product offerings include aTSA and rTSA systems, designed to address patient and surgeon needs through customizable components for anatomic or reverse configurations. The company's ecosystem encompasses enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration. Shoulder Innovations Inc emphasizes improving preoperative planning, implant design, and procedural efficiency to benefit stakeholders across the care chain. The company's website is shoulderinnovations.com, and it is positioned as a commercial-stage medical technology firm. The company's operational details, including its focus on shoulder surgical care and its product systems, are central to its business model. The company's IPO date is set for July 31, 2025, marking a significant milestone in its growth trajectory. The company's approach integrates advanced implant systems with supporting technologies to enhance surgical outcomes and streamline care processes. Shoulder Innovations is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shoulder Innovations stock

Debt-to-Assets Ratio of Shoulder Innovations is 0.09 in 2025.

Debt-to-Assets Ratio of Shoulder Innovations changed from 0.34 to 0.09, representing a -74.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt-to-Assets Ratio Shoulder Innovations since 2006 – with annual values, charts, and detailed analysis.

The Debt-to-Assets ratio measures what percentage of a company's assets are financed through debt. Higher ratios indicate greater financial risk.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt-to-Assets Ratio's Shoulder Innovations with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Shoulder Innovations

All Key Metrics — Shoulder Innovations